Stay updated on Midostaurin Combo with Chemo in FLT3 AML Clinical Trial

Sign up to get notified when there's something new on the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page shows an update of the revision tag from v3.3.3 to v3.3.4, with no visible changes to study content or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T07:00:20.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Locations section updated with a broad set of new site entries and regional designations (e.g., Bayonne Cedex, Pays de la Loire Region, Slovak Republic, Balearic Islands, Basque Country, Catalonia, Madrid, Santa Cruz De Tenerife, etc.), and several former location groupings were removed.
    Difference
    2%
    Check dated 2025-12-18T21:53:23.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    A note now states that publications are automatically filled from PubMed and may not all pertain to the study; the revision has been updated to v3.3.2 (from v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-26T23:39:02.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Deletion of the government funding/status notice from the page; the study details and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-19T21:42:37.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots. Page content and layout appear unchanged, including the Study Overview, Eligibility Criteria, and Contacts sections.
    Difference
    0.2%
    Check dated 2025-10-29T02:54:24.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice with operating status guidance and links; included current operating status reminders. - Updated version to v3.2.0 and removed the old v3.0.2 reference.
    Difference
    2%
    Check dated 2025-10-07T13:54:11.000Z thumbnail image

Stay in the know with updates to Midostaurin Combo with Chemo in FLT3 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page.